| Product NDC: | 0378-0872 |
| Proprietary Name: | Clonidine |
| Non Proprietary Name: | clonidine |
| Active Ingredient(s): | .2 mg/d & nbsp; clonidine |
| Administration Route(s): | TRANSDERMAL |
| Dosage Form(s): | PATCH |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0378-0872 |
| Labeler Name: | Mylan Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076166 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130208 |
| Package NDC: | 0378-0872-99 |
| Package Description: | 4 POUCH in 1 CARTON (0378-0872-99) > 1 PATCH in 1 POUCH (0378-0872-16) > 7 d in 1 PATCH |
| NDC Code | 0378-0872-99 |
| Proprietary Name | Clonidine |
| Package Description | 4 POUCH in 1 CARTON (0378-0872-99) > 1 PATCH in 1 POUCH (0378-0872-16) > 7 d in 1 PATCH |
| Product NDC | 0378-0872 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | clonidine |
| Dosage Form Name | PATCH |
| Route Name | TRANSDERMAL |
| Start Marketing Date | 20130208 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | CLONIDINE |
| Strength Number | .2 |
| Strength Unit | mg/d |
| Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |